Efficus Life Sciences And Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 03-01-2025
- Paid Up Capital ₹ 0.80 M
as on 03-01-2025
- Company Age 7 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 9.50 M
as on 03-01-2025
- Satisfied Charges ₹ 0.69 M
as on 03-01-2025
- Revenue -35.00%
(FY 2021)
- Profit -93.53%
(FY 2021)
- Ebitda -1140.41%
(FY 2021)
- Net Worth 1.66%
(FY 2021)
- Total Assets 8.40%
(FY 2021)
About Efficus Life Sciences And Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.80 M.
The company currently has active open charges totaling ₹9.50 M. The company has closed loans amounting to ₹0.69 M, as per Ministry of Corporate Affairs (MCA) records.
Chavercode Rose, Sajith Kamalasanan, Kamalasanan Ajith, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24304KL2017PTC048683
- Company No.
048683
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Mar 2017
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Company Details
- Location
Thiruvananthapuram, Kerala, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Efficus Life Sciences And Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kamalasanan Ajith  | Managing Director | 24-Mar-2017 | Current |
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Chavercode Rose | Director | 24-Mar-2017 | Current |
| Sajith Kamalasanan | Director | 06-Apr-2017 | Current |
| Rema Vidyadharan | Director | 26-Sep-2017 | Current |
| Chavercode Honey | Director | 06-Apr-2017 | Current |
Financial Performance of Efficus Life Sciences And Pharmaceuticals.
Efficus Life Sciences And Pharmaceuticals Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 35% decrease. The company also saw a substantial fall in profitability, with a 93.53% decrease in profit. The company's net worth moved up by a moderate rise of 1.66%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Efficus Life Sciences And Pharmaceuticals?
In 2021, Efficus Life Sciences And Pharmaceuticals had a promoter holding of 70.00% and a public holding of 30.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Medic Biologicals And Pharmaceuticals Private LimitedActive 13 years 11 monthsChavercode Rose, Sajith Kamalasanan and 3 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 25 Nov 2019 | ₹8.50 M | Open |
Others Creation Date: 30 Jan 2018 | ₹1.00 M | Open |
Others Creation Date: 19 Jun 2020 | ₹0.69 M | Satisfied |
How Many Employees Work at Efficus Life Sciences And Pharmaceuticals?
Unlock and access historical data on people associated with Efficus Life Sciences And Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Efficus Life Sciences And Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Efficus Life Sciences And Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
